| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database
|
Barco, Stefano
|
|
|
9 |
1 |
p. 33-42
|
artikel
|
| 2 |
An almanac of pandemonium
|
Das, Anindita
|
|
|
9 |
1 |
p. 15-17
|
artikel
|
| 3 |
An asthma plan
|
Wilson, Mark
|
|
|
9 |
1 |
p. 18-20
|
artikel
|
| 4 |
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19
|
Dhawan, Ranju T
|
|
|
9 |
1 |
p. 107-116
|
artikel
|
| 5 |
Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
|
Heaney, Liam G
|
|
|
9 |
1 |
p. 57-68
|
artikel
|
| 6 |
Correction to Lancet Respir Med 2020; 8: 795–806
|
|
|
|
9 |
1 |
p. e10
|
artikel
|
| 7 |
Corticosteroids for COVID-19: the search for an optimum duration of therapy
|
Mishra, Gyanshankar P
|
|
|
9 |
1 |
p. e8
|
artikel
|
| 8 |
Effectiveness of fevipiprant in reducing exacerbations in patients with severe asthma (LUSTER-1 and LUSTER-2): two phase 3 randomised controlled trials
|
Brightling, Christopher E
|
|
|
9 |
1 |
p. 43-56
|
artikel
|
| 9 |
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
|
Highland, Kristin B
|
|
|
9 |
1 |
p. 96-106
|
artikel
|
| 10 |
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
|
Lee, Laurie A
|
|
|
9 |
1 |
p. 69-84
|
artikel
|
| 11 |
Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial
|
Behr, Jürgen
|
|
|
9 |
1 |
p. 85-95
|
artikel
|
| 12 |
Facemasks as a COVID-19 barrier: a window into the overlooked experience of chronic dyspnoea?
|
Similowski, Thomas
|
|
|
9 |
1 |
p. 12-13
|
artikel
|
| 13 |
Implementing rapid diagnostics for COVID-19
|
Nimmo, Camus
|
|
|
9 |
1 |
p. e7
|
artikel
|
| 14 |
Juntos en la pandemia de COVID-19 (together in the COVID-19 pandemic): health-care professionals and the Latinx community
|
Zaeh, Sandra E
|
|
|
9 |
1 |
p. 13-15
|
artikel
|
| 15 |
More options for managing severe asthma in adults
|
Chang, Anne B
|
|
|
9 |
1 |
p. 3-5
|
artikel
|
| 16 |
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial
|
Cunningham, Steve
|
|
|
9 |
1 |
p. 21-32
|
artikel
|
| 17 |
Overdiagnosis in lung cancer screening
|
Callister, Matthew E J
|
|
|
9 |
1 |
p. 7-9
|
artikel
|
| 18 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Tsolaki, Vasiliki
|
|
|
9 |
1 |
p. e2
|
artikel
|
| 19 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Narayan, Ananthu
|
|
|
9 |
1 |
p. e3
|
artikel
|
| 20 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Camporota, Luigi
|
|
|
9 |
1 |
p. e1
|
artikel
|
| 21 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome
|
Dandel, Michael
|
|
|
9 |
1 |
p. e4
|
artikel
|
| 22 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome – Authors' reply
|
Grasselli, Giacomo
|
|
|
9 |
1 |
p. e5-e6
|
artikel
|
| 23 |
Personalised medicine for asthma in a post-pandemic world
|
The Lancet Respiratory Medicine,
|
|
|
9 |
1 |
p. 1
|
artikel
|
| 24 |
Prostaglandin D2: the end of a story or just the beginning?
|
Kerstjens, Huib A M
|
|
|
9 |
1 |
p. 2-3
|
artikel
|
| 25 |
Sepsis: the importance of an accurate final diagnosis
|
Tidswell, Robert
|
|
|
9 |
1 |
p. 17-18
|
artikel
|
| 26 |
The role of interferons in preschool wheeze
|
Makrinioti, Heidi
|
|
|
9 |
1 |
p. 9-11
|
artikel
|
| 27 |
Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
|
Oldham, Justin M
|
|
|
9 |
1 |
p. 5-7
|
artikel
|
| 28 |
US presidential election results, and the future of WHO and the Paris Agreement
|
Burki, Talha Khan
|
|
|
9 |
1 |
p. e9
|
artikel
|
Tijdschrift beschrijving